These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25418270)

  • 1. Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.
    Sood J; Sapra B; Bhandari S; Jindal M; Tiwary AK
    Ther Deliv; 2014 Oct; 5(10):1123-42. PubMed ID: 25418270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.
    Cooper VB; Pearce GE; Petts CR
    J Pharm Pharmacol; 2003 Sep; 55(9):1323-9. PubMed ID: 14604477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid conversion of API hydrates to anhydrous forms in aqueous media.
    Petrova RI; Peresypkin A; Mortko CJ; McKeown AE; Lee J; Williams JM
    J Pharm Sci; 2009 Nov; 98(11):4111-8. PubMed ID: 19384923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure and solid-state studies of aged samples of tienoxolol, an API designed against hypertension.
    Mahé N; Do B; Nicolaï B; Rietveld IB; Barrio M; Tamarit JL; Céolin R; Guéchot C; Teulon JM
    Int J Pharm; 2012 Jan; 422(1-2):47-51. PubMed ID: 22027392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying crystallisation rates of amorphous pharmaceuticals with dynamic mechanical analysis (DMA).
    Soutari N; Buanz AB; Gul MO; Tuleu C; Gaisford S
    Int J Pharm; 2012 Feb; 423(2):335-40. PubMed ID: 22101291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.
    Kawakami K; Usui T; Hattori M
    J Pharm Sci; 2012 Sep; 101(9):3239-48. PubMed ID: 22531946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New technology for the investigation of water vapor sorption-induced crystallographic form transformations of chemical compounds: a water vapor sorption gravimetry-dispersive Raman spectroscopy coupling.
    Feth MP; Jurascheck J; Spitzenberg M; Dillenz J; Bertele G; Stark H
    J Pharm Sci; 2011 Mar; 100(3):1080-92. PubMed ID: 20740677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.
    Bao Y; Mo X; Xu X; He Y; Xu X; An H
    J Pharm Biomed Anal; 2008 Nov; 48(3):664-71. PubMed ID: 18678459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation, physical stability, and quantification of process-induced disorder in cryomilled samples of a model polymorphic drug.
    Hu Y; Macfhionnghaile P; Caron V; Tajber L; Healy AM; Erxleben A; McArdle P
    J Pharm Sci; 2013 Jan; 102(1):93-103. PubMed ID: 23047833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing pseudopolymorphic transitions in pharmaceutical solids using Raman spectroscopy: hydration and dehydration of theophylline.
    Amado AM; Nolasco MM; Ribeiro-Claro PJ
    J Pharm Sci; 2007 May; 96(5):1366-79. PubMed ID: 17455358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid state amorphization of pharmaceuticals.
    Willart JF; Descamps M
    Mol Pharm; 2008; 5(6):905-20. PubMed ID: 18954076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g).
    Descamps M; Willart JF; Dudognon E; Caron V
    J Pharm Sci; 2007 May; 96(5):1398-407. PubMed ID: 17455353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the influence of counterion on the properties of some amorphous organic salts.
    Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
    Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic Principles of Lyophilization, Part 1.
    Akers MJ
    Int J Pharm Compd; 2015; 19(6):471-6. PubMed ID: 26891561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of water in the physical stability of solid dosage formulations.
    Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
    J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.
    Ticehurst MD; Marziano I
    J Pharm Pharmacol; 2015 Jun; 67(6):782-802. PubMed ID: 25677227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.